KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Restructuring Costs: 2014-2024

Historic Restructuring Costs for Arbutus Biopharma (ABUS) over the last 6 years, with Dec 2024 value amounting to $3.7 million.

  • Arbutus Biopharma's Restructuring Costs fell 97.30% to $98,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 234.89%. This contributed to the annual value of $3.7 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Arbutus Biopharma's Restructuring Costs is $3.7 million, which was up 5,712.50% from $64,000 recorded in FY2020.
  • Arbutus Biopharma's 5-year Restructuring Costs high stood at $3.7 million for FY2024, and its period low was $64,000 during FY2020.
  • Moreover, its 1-year median value for Restructuring Costs was $3.7 million (2024), whereas its average is $3.7 million.
  • Data for Arbutus Biopharma's Restructuring Costs shows a maximum YoY crashed of 58.97% (in 2020) over the last 5 years.
  • Over the past 2 years, Arbutus Biopharma's Restructuring Costs (Yearly) stood at $64,000 in 2020, then followed by $3.7 million in 2024.